These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood. Eindor-Abarbanel A; Healey GR; Jacobson K Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830388 [TBL] [Abstract][Full Text] [Related]
24. The role of the gut microbiota and microbial metabolites in neuroinflammation. Haase S; Wilck N; Haghikia A; Gold R; Mueller DN; Linker RA Eur J Immunol; 2020 Dec; 50(12):1863-1870. PubMed ID: 33188704 [TBL] [Abstract][Full Text] [Related]
25. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Peterson CT; Sharma V; Elmén L; Peterson SN Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825 [TBL] [Abstract][Full Text] [Related]
27. The second brain: The connection between gut microbiota composition and multiple sclerosis. Farshbafnadi M; Agah E; Rezaei N J Neuroimmunol; 2021 Nov; 360():577700. PubMed ID: 34482269 [TBL] [Abstract][Full Text] [Related]
28. Microbial dysbiosis in the gut drives systemic autoimmune diseases. Mousa WK; Chehadeh F; Husband S Front Immunol; 2022; 13():906258. PubMed ID: 36341463 [TBL] [Abstract][Full Text] [Related]
29. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities. Brunkwall L; Orho-Melander M Diabetologia; 2017 Jun; 60(6):943-951. PubMed ID: 28434033 [TBL] [Abstract][Full Text] [Related]
30. Impacts of microbiome metabolites on immune regulation and autoimmunity. Haase S; Haghikia A; Wilck N; Müller DN; Linker RA Immunology; 2018 Jun; 154(2):230-238. PubMed ID: 29637999 [TBL] [Abstract][Full Text] [Related]
31. The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis. Freedman SN; Shahi SK; Mangalam AK Neurotherapeutics; 2018 Jan; 15(1):109-125. PubMed ID: 29204955 [TBL] [Abstract][Full Text] [Related]
32. Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises. Leclercq S; de Timary P; Stärkel P Acta Gastroenterol Belg; 2020; 83(4):616-621. PubMed ID: 33321019 [TBL] [Abstract][Full Text] [Related]
33. The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota. Milani C; Duranti S; Bottacini F; Casey E; Turroni F; Mahony J; Belzer C; Delgado Palacio S; Arboleya Montes S; Mancabelli L; Lugli GA; Rodriguez JM; Bode L; de Vos W; Gueimonde M; Margolles A; van Sinderen D; Ventura M Microbiol Mol Biol Rev; 2017 Dec; 81(4):. PubMed ID: 29118049 [TBL] [Abstract][Full Text] [Related]
34. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT). Lee P; Yacyshyn BR; Yacyshyn MB Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245 [TBL] [Abstract][Full Text] [Related]
35. Microbial communities modulating brain functioning and behaviors in zebrafish: A mechanistic approach. Mohanta L; Das BC; Patri M Microb Pathog; 2020 Aug; 145():104251. PubMed ID: 32418919 [TBL] [Abstract][Full Text] [Related]
36. Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis. Mestre L; Carrillo-Salinas FJ; Mecha M; Feliú A; Guaza C Biochem Pharmacol; 2018 Nov; 157():51-66. PubMed ID: 30171835 [TBL] [Abstract][Full Text] [Related]
37. Gut microbiota: impacts on gastrointestinal cancer immunotherapy. Lau HCH; Sung JJ; Yu J Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800 [TBL] [Abstract][Full Text] [Related]
38. Gut-oriented interventions in patients with multiple sclerosis: fact or fiction? Martinelli V; Albanese M; Altieri M; Annovazzi P; Arabi S; Bucello S; Caleri F; Cerqua R; Costanzi C; Cottone S; Dalla Costa G; Direnzo V; Fantozzi R; Favaretto A; Lorefice L; Montini F; Noce A; Plewnia K; Repice AM; Sacco R; Vecchio D Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):935-946. PubMed ID: 35179760 [TBL] [Abstract][Full Text] [Related]
39. Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases. Mahmud MR; Akter S; Tamanna SK; Mazumder L; Esti IZ; Banerjee S; Akter S; Hasan MR; Acharjee M; Hossain MS; Pirttilä AM Gut Microbes; 2022; 14(1):2096995. PubMed ID: 35866234 [TBL] [Abstract][Full Text] [Related]
40. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis. Haak BW; Prescott HC; Wiersinga WJ Front Immunol; 2018; 9():2042. PubMed ID: 30250472 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]